Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It has been shown that patients can improve their safety through informed choice, safe medication use, and complication reporting. This includes not only the potential problems that occur from prescription medication use but also issues that may arise through the improper use of over-the-counter medications. The willingness of a patient to take on safety action is known to be complicated by an unwillingness to behave in a manner that might challenge a physician's judgment or actions. Community pharmacists are in the unique position to provide perspective on the physician's recommendation and act as an advocate to facilitate necessary change. Through supportive and repeated interaction with their community pharmacist patients will develop assertiveness toward their own health care, an increased frequency and quality of interaction with their physician, and thus a minimized risk of harm and maximized opportunity to optimize clinical outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Trial to De-prescribe Inappropriate Medications in the Community Dwelling Elderly

NCT02053194

Inappropriate Dose of Drug Administered Health Behavior

COMPLETED PHASE4

Pharmacist-led Interventions to Improve Medication Use

NCT05346770

Pharmacogenomics Old Age

UNKNOWN

Using Clinical Alerts to Decrease Inappropriate Medication Prescribing

NCT01034761

Elderly

COMPLETED NA

Enhancing Timely Access to Medication Changes: The Role of Pharmacists in Overcoming Transitions of Care Challenges

NCT07018232

Transitional Care

COMPLETED

Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy

NCT02026453

Adverse Drug Events

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single center, observational study to determine if geriatric patients who are on five or more chronic medications will have a difference in clinical, humanistic, and/or economic outcome through an integrated clinical pharmacy service intervention. The primary efficacy objective will be assessed through a single cohort, paired research design measuring the change from baseline in the adherence rate, number of medication related problems, and Beers criteria medications. The primary economic objective will be assessed through prescription revenue to validate the employment of a 0.5-1.0 Full-time equivalent (FTE). Secondary efficacy objectives will be assessed through a single cohort, paired research design measuring the change from baseline in the health literacy, optimization in the anthropometrics, and health related quality of life (HRQOL).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Adherence Health Literacy Geriatric Patient Care Improvement Pharmacy Economic Improvement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Age 65 years or over AND at least 5 chronic medications

Group Type OTHER

Medication adherence consultation

Intervention Type BEHAVIORAL

Patients will be counseled in person on day 0 then telephonically every month after until day 365.

Medication problems assessment

Intervention Type OTHER

Patients will be asked if they are having any issues that may be attributable to their current drug therapy on a monthly basis. Any issue that is identified will be addressed by the pharmacist.

Beer's Criteria Assessment

Intervention Type OTHER

The patient's drug therapy will be reviewed for Beer's criteria medications and possible alternatives will be addressed by the pharmacist if deemed appropriate.

Health Literacy Assessment

Intervention Type BEHAVIORAL

Patients will be given a Health Literacy Assessment on day 0 and day 365 using the Realm-SF.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medication adherence consultation

Patients will be counseled in person on day 0 then telephonically every month after until day 365.

Intervention Type BEHAVIORAL

Medication problems assessment

Patients will be asked if they are having any issues that may be attributable to their current drug therapy on a monthly basis. Any issue that is identified will be addressed by the pharmacist.

Intervention Type OTHER

Beer's Criteria Assessment

The patient's drug therapy will be reviewed for Beer's criteria medications and possible alternatives will be addressed by the pharmacist if deemed appropriate.

Intervention Type OTHER

Health Literacy Assessment

Patients will be given a Health Literacy Assessment on day 0 and day 365 using the Realm-SF.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are at least 65 years of age
* Have at least 5 medications that they take on a chronic basis
* Willing to have their prescriptions filled by VascuScript Pharmacy
* Understand the terms of the informed consent

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes